Harmony Biosciences Holdings, Inc. (HRMY) stock
HRMYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 18/3039% below fair value
$33.01+0.05 (+0.15%)
Close on Nov 17, 2026Market cap $1.92BP/E 10.7Yield –
Harmony Biosciences operating margin
Operating margin is operating income as a percentage of revenue.
Harmony Biosciences's operating margin for the twelve months ending Jun 30, 2026 was 24.0%. For fiscal 2025 it was 24.0%, against 26.7% the year before. The highest annual figure on record is 33.0% in fiscal 2023.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 24.0% | −2.7 |
| FY2024 | Dec 31, 2024 | 26.7% | −6.3 |
| FY2023 | Dec 31, 2023 | 33.0% | +5.5 |
| FY2022 | Dec 31, 2022 | 27.4% | −1.2 |
| FY2021 | Dec 31, 2021 | 28.7% | +18.0 |
| FY2020 | Dec 31, 2020 | 10.6% | +2444.4 |
| FY2019 | Dec 31, 2019 | -2433.8% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 34.2% | +10.2 |
| Q1 FY2026 | Mar 31, 2026 | 17.3% | −13.1 |
| Q4 FY2025 | Dec 31, 2025 | 15.8% | −11.9 |
| Q3 FY2025 | Sep 30, 2025 | 27.3% | −5.8 |
| Q2 FY2025 | Jun 30, 2025 | 24.0% | +11.7 |
| Q1 FY2025 | Mar 31, 2025 | 30.4% | −3.2 |
| Q4 FY2024 | Dec 31, 2024 | 27.7% | +3.8 |
| Q3 FY2024 | Sep 30, 2024 | 33.2% | −7.1 |
| Q2 FY2024 | Jun 30, 2024 | 12.4% | −22.6 |
| Q1 FY2024 | Mar 31, 2024 | 33.7% | −0.3 |
| Q4 FY2023 | Dec 31, 2023 | 23.9% | −13.2 |
| Q3 FY2023 | Sep 30, 2023 | 40.3% | +30.1 |
| Q2 FY2023 | Jun 30, 2023 | 34.9% | +4.0 |
| Q1 FY2023 | Mar 31, 2023 | 33.9% | +1.6 |
| Q4 FY2022 | Dec 31, 2022 | 37.1% | +5.7 |
| Q3 FY2022 | Sep 30, 2022 | 10.2% | −15.9 |
| Q2 FY2022 | Jun 30, 2022 | 30.9% | −0.6 |
| Q1 FY2022 | Mar 31, 2022 | 32.3% | +7.9 |
| Q4 FY2021 | Dec 31, 2021 | 31.4% | +17.6 |
| Q3 FY2021 | Sep 30, 2021 | 26.1% | +3.3 |
| Q2 FY2021 | Jun 30, 2021 | 31.6% | +12.3 |
| Q1 FY2021 | Mar 31, 2021 | 24.4% | +72.8 |
| Q4 FY2020 | Dec 31, 2020 | 13.8% | – |
| Q3 FY2020 | Sep 30, 2020 | 22.8% | – |
| Q2 FY2020 | Jun 30, 2020 | 19.2% | – |
| Q1 FY2020 | Mar 31, 2020 | -48.4% | – |
See a number that looks wrong?